flesinoxan has been researched along with uh 301 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
Groenink, L; Maes, RA; Mos, J; Olivier, B; Van der Gugten, J | 1 |
Gommans, J; Hijzen, TH; Maes, RA; Mos, J; Olivier, B | 1 |
3 other study(ies) available for flesinoxan and uh 301
Article | Year |
---|---|
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Blood Glucose; Corticosterone; Male; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 1995 |
Discriminative stimulus properties of flesinoxan: effects of enantiomers, (S)-UH301 and WAY-100635.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Analgesics, Opioid; Animals; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Fentanyl; Generalization, Psychological; Injections, Subcutaneous; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Serotonin Antagonists; Stereoisomerism | 1995 |